Nontuberculous mycobacteria in the setting of cystic fibrosis (Q34949950)

5 August 2017

1 reference

title

Nontuberculous mycobacteria in the setting of cystic fibrosis (English)

1 reference

5 August 2017

0 references

Deborah L Ebert

1

1 reference

PubMed ID

12371001

5 August 2017

Kenneth N Olivier

series ordinal

2

1 reference

5 August 2017

1 September 2002

1 reference

Clinics in Chest Medicine

5 August 2017

1 reference

5 August 2017

23

1 reference

5 August 2017

3

1 reference

5 August 2017

655-663

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

5 August 2017

1 reference

7 January 2021

Microbiology of sputum from patients at cystic fibrosis centers in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Epidemiology of infection by nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Nontuberculous Mycobacterial Infections of the Lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Isolation of nontuberculous mycobacteria in the United States, 1980

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Nontuberculous mycobacteria. An underappreciated cause of geriatric lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Intrathoracic Mycobacterium avium complex infection in immunocompetent children: case report and review

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Nontuberculous mycobacterial disease in adult cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Mycobacterial lung disease in cystic fibrosis: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Prospective study of mycobacterial infections in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

The role of Mycobacteria Other Than Tuberculosis (MOTT) in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Bacterial infection in cystic fibrosis (CF): special reference to mycobacteria and Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Nontuberculous Mycobacteria in Adult Patients with Cystic Fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Pulmonary disease caused by Mycobacterium kansasii in a patient with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Non-tuberculous mycobacteria in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Multiple brain abscesses in a 25-year-old patient with cystic fibrosis, successfully treated with an anti-Pseudomonas plus anti-mycobacterial antibiotic regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Proficiency testing of clinical microbiology laboratories using modified decontamination procedures for detection of nontuberculous mycobacteria in sputum samples from cystic fibrosis patients. The Nontuberculous Mycobacteria in Cystic Fibrosis Stud

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Isolation of rapidly growing mycobacteria in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Nontuberculous mycobacteria in cystic fibrosis. An autopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Computed tomographic diagnosis of Mycobacterium avium-intracellulare complex in patients with bronchiectasis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

CT findings in 14 patients with Mycobacterium chelonae pulmonary infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Evaluation of the clinical usefulness of mycobacterial skin test antigens in adults with pulmonary mycobacterioses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Dual skin testing with Mycobacterium avium sensitin and purified protein derivative: an open study of patients with M. avium complex infection or tuberculosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Skin testing with Mycobacterium avium sensitin to identify infection with M. avium complex in patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Diagnosis and Treatment of Disease Caused by Nontuberculous Mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Serum concentrations of the antimycobacterial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Initial clarithromycin monotherapy for Mycobacterium avium-intracellulare complex lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Clarithromycin regimens for pulmonary Mycobacterium avium complex. The first 50 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Results of operation in Mycobacterium avium-intracellulare lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Pneumonectomy in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Predicting outcome following pulmonary resection in cystic fibrosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Aerosolized interferon gamma for Mycobacterium avium-complex lung disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Treatment of refractory disseminated Mycobacterium abscessus infection with interferon gamma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Pulmonary disease caused by Mycobacterium chelonae in a heart-lung transplant recipient with obliterative bronchiolitis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Mycobacterium avium complex in a patient with cystic fibrosis: disease vs. colonization

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Infectious complications of lung transplantation. Impact of cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

Mycobacterial infections in lung transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

The spectrum of mycobacterial infection after lung transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2802%2900017-5

7 January 2021

10.1016/S0272-5231(02)00017-5

Identifiers

DOI

1 reference

5 August 2017

1 reference

PubMed ID

12371001